There are a lot of good ideas for improving health care, but we don’t know if they work til comprehensive research is done to ascertain the effects of implementation. And doing research is often not easy, so the absence of evidence doesn’t mean absence of benefit. The Agency for Healthcare Research and Quality has commissioned a series of reviews of initiatives and the most recent looked at outpatient case management. (AHRQ Report) As is often the case, one difficulty in assembling the evidence is the lack of consistent definitions or consistent intervention techniques. There were a total of 109 applicable studies reviewed, for a variety of illnesses, generally chronic. The summary of the studies concluded that there was only a small change in quality outcomes, patient satisfaction or experience of care and health care utilization or spending, although some studies showed significant effects on one or more of these outcomes. While care management interventions were diverse, some characteristics that appeared associated with better outcomes were more intense care management–longer contact times, longer duration of the intervention, face-to-face contacts and more integration with the patient’s usual sources of care. Overall, one could conclude that case management has the potential to improve outcomes, but an optimal set of interventions for specific diseases or patient characteristics or situations has not yet been discovered. Further research may uncover that set of interventions, which if consistently executed, would improve both quality and cost.
Outpatient Case Management
By Kevin RocheOctober 2, 2013Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 27, 2023
Why You Can’t Trust People Who Make Up Stuff About Vax Safety
A couple of studies offer a far better explanation for heart issues in athletes and…
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…